BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics.
10.12122/j.issn.1673-4254.2020.05.11
- Author:
Xiaoyan LI
1
;
Jie HE
2
;
Mi YU
2
;
Wei ZHANG
2
;
Jian SUN
2
Author Information
1. Department of endocrinology, First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China.
2. Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China.
- Publication Type:Journal Article
- Keywords:
BUB1 gene;
bioinformatics;
gastric cancer;
survival
- MeSH:
Computational Biology;
Humans;
Kaplan-Meier Estimate;
Prognosis;
Protein-Serine-Threonine Kinases;
genetics;
Stomach Neoplasms;
genetics;
Tumor Microenvironment
- From:
Journal of Southern Medical University
2020;40(5):683-692
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the expression of BUB1 gene in gastric cancer.
METHODS:Oncomine, GEPIA, BioGPS and Kaplan-Meier Plotter databases were used to analyze the difference of BUB1 gene expression between gastric cancer tissue and normal gastric tissue. The association of BUB1 expression level with the prognosis of gastric cancer patients was also analyzed. The Cancer Cell Line Encyclopedia (CCLE) was explored to analyze the expression of BUB1 in T cells and B cells in gastric cancer patients, and the String database was used to generate the network map of BUB1-related proteins and functional annotation of gene ontology (GO). The related pathways of KEGG were analyzed. Tumor immune assessment resource (TIMER) database was used to analyze the expression of BUB1 in immune infiltration and its effect on prognosis of gastric cancer patients. To further verify the results of gene chip analysis in Oncomine database, we collected 30 pairs of surgical specimens of gastric adenocarcinoma and adjacent tissues from patients admitted to the First Affiliated Hospital of Chengdu Medical College from March, 2018 to July, 2019. The results of BUB1 gene expression in Oncomine database were verified by PCR and immunohistochemistry.
RESULTS:Oncomine, GEPIA and BioGPS analyses showed that BUB1 was highly expressed in gastric cancer compared with normal gastric tissue. Kaplan-Meier survival analysis showed that the progression-free survival time (HR=0.52, 95% :0.41-0.67, < 0.05) and the overall survival time (HR=0.67, 95% :0.55-0.82, < 0.05) were prolonged in gastric cancer patients with a high expression of BUB1. Through String data collection, BUB1-related proteins were mainly enriched in 13 cellular components, 4 molecular functions and 12 biological processes, involving 4 signal pathways. TIMER database analysis showed that CD4 T cells and macrophages with high expressions of BUB1 mRNA in the immune microenvironment were associated with a favorable 5-year survival outcome of patients with gastric cancer. In the surgical specimens, real-time quantitative PCR showed that the expression level of BUB1 mRNA was significantly higher in gastric cancer tissues than in the adjacent gastric mucosa tissues, and immunohistochemical results demonstrated positive BUB1 staining in the gastric cancer tissues.
CONCLUSIONS:BUB1 gene is highly expressed in gastric cancer. BUB1 may reduce tumor immunosuppression and helps to evaluate the prognosis of patients with gastric cancer.
